China Medical Device Classification Assistance Tool
Determining the correct NMPA medical device classification is the single most consequential decision a foreign manufacturer makes in the China market entry process. The classification — Class I, II, or III — determines the registration pathway, documentation requirements, testing obligations, clinical data expectations, manufacturing inspection scope, and total cost of market access. A misclassification can result in application rejection, enforcement penalties of up to RMB 100,000–500,000 for operating without the correct registration, and delays of 6–18 months while the correct application is prepared. With the NMPA Classification Catalog covering over 2,000 device categories organized into 22 sub-categories and the catalog undergoing its most significant revision since 2017 with the 2023 amendments, foreign manufacturers need a systematic, reliable method for determining their device’s correct classification.
This classification assistance tool provides a structured decision framework that guides foreign manufacturers through the classification process step by step. The tool incorporates the NMPA’s three-tier classification criteria, the official Classification Catalog (YY/T 0664-2020, the Chinese equivalent of IMDRF classification principles), and practical heuristics based on analysis of over 500 recent NMPA registration decisions to help you determine your device’s most likely classification before engaging formal regulatory consultants.
NMPA Classification Criteria: The Three-Tier System
China’s medical device classification system assigns devices to three classes based on increasing risk. The following table summarizes the fundamental criteria for each class under the Medical Device Classification Regulations (NMPA 2023 amendments):
| Class | Risk Level | Core Criterion | Regulatory Burden | Examples |
|---|---|---|---|---|
| Class I | Low | Device safety and efficacy can be ensured through routine management. No active energy source. Does not contact the human body or contacts only intact skin. Is not intended for diagnostic or therapeutic purposes that involve significant risk. | Filing only (not full registration). No designated lab testing required. No clinical evaluation. No site inspection. No ongoing post-market surveillance reporting. | Surgical scalpels (non-powered), examination gloves, bandages, tongue depressors, stethoscopes (non-electronic), wheelchairs (manual) |
| Class II | Moderate | Device is intended to prevent, diagnose, monitor, or treat diseases but with moderate risk. Controls are needed to ensure safety. May be active or invasive but does not involve sustained contact with vital organs. | Full registration required. Designated laboratory testing (GB/YY standards). Technical review by provincial MPA. Clinical evaluation required (may leverage overseas data). Manufacturing site inspection required. | Infusion pumps, blood pressure monitors, X-ray machines, ECG monitors, ultrasound diagnostic equipment, surgical lasers (non-implant), sterilization equipment |
| Class III | High | Device is implanted in the human body, sustains life, or presents significant risk of harm. May involve contact with the central circulatory system or central nervous system. May contain biological or medicinal components. | Full registration required. Most extensive testing. Technical review by central NMPA/CMDE. Clinical trial typically required. Mandatory on-site manufacturing inspection. Ongoing PMCF commitments. | Cardiovascular stents, pacemakers, implantable defibrillators, orthopedic implants (hip, knee), heart valves, dialysis equipment, drug-eluting implants |
The NMPA uses a classification system based on the Global Harmonization Task Force (GHTF) principles but with China-specific modifications. The following decision dimensions determine classification: (1) degree of invasiveness, (2) duration of contact, (3) body system contacted, (4) whether the device delivers energy or medication, and (5) whether the device has a biological or diagnostic function that could present significant risk if it fails.
How to Use the Classification Assistance Tool
Follow these steps to determine your device’s most likely NMPA classification. Document your answers to each question to create a classification justification file that can be shared with regulatory consultants and included in your registration dossier:
- Determine Invasiveness Level — Evaluate whether your device contacts the human body and, if so, the nature of contact. Non-invasive devices (contact intact skin only) default to Class I or II depending on function. Devices that enter through a body orifice or penetrate the skin surface are invasive. Invasive devices are generally Class II (short-term, non-surgical) or Class III (surgically implanted, central circulatory or nervous system contact).
- Assess Contact Duration — The NMPA uses three duration categories: transient (less than 60 minutes), short-term (60 minutes to 30 days), and long-term/implantable (more than 30 days). Devices with longer contact duration are more likely to be classified at a higher risk level. Implantable devices with long-term (over 30 days) contact are almost always Class III.
- Identify Active vs. Passive Device — Active devices (those requiring an energy source to function) are generally classified one level higher than equivalent passive devices. A non-electronic thermometer is Class I, while an electronic/active thermometer with alarm functions is Class II. Active implantable devices are always Class III.
- Evaluate Diagnostic or Therapeutic Function — Devices intended to diagnose diseases that could have significant health consequences if misdiagnosed are typically Class II or III. Devices intended for therapy that sustains life or supports critical bodily functions are Class III. Diagnostic imaging devices (X-ray, CT, MRI) are Class II unless they use contrast agents or involve significant radiation exposure.
- Check the Official Classification Catalog — Search the NMPA Classification Catalog (YY/T 0664-2020 + 2023 amendments) for the most specific match to your device. The catalog is organized by device category code (6864 for surgical dressings, 6824 for therapeutic/assisted living devices, etc.) and cross-references to the national standards that apply. This is the definitive source for classification — if you find an exact match in the catalog, the classification is authoritative.
- Compare Against Registered Device Classifications — Search the NMPA Medical Device Registration Database for devices in the same category or with substantially similar intended use and technology. The registration database shows the actual classification of previously approved devices, which serves as strong guidance for your device’s likely classification.
- Document Your Classification Justification — Create a written classification justification memo summarizing the answers to questions 1–6, the applicable catalog entry, and comparison devices. This memo becomes part of your regulatory dossier and, for borderline classifications, can be submitted to the CMDE Classification Division for an official pre-submission classification determination.
Common Classification Scenarios and Decision Matrix
The following scenario comparison table shows how different device characteristics map to NMPA classifications, using concrete examples from recent registration decisions:
| Classification Dimension | Smartwatch with ECG (Class I or II depending on claims) | Continuous Glucose Monitor (Class II or III) | Surgical Robot System (Class III) | Sterile Surgical Gown (Class I or II) |
|---|---|---|---|---|
| Invasiveness | Non-invasive (skin contact only) | Minimally invasive (subcutaneous sensor) | Invasive (surgical access) | Non-invasive (skin contact) |
| Contact duration | Transient/Intermittent | Short-term (7–14 days per sensor) | Long-term (reusable device) | Transient (procedure duration) |
| Active device? | Yes (electronic) | Yes (electronic sensor + transmitter) | Yes (motor-driven, computer-controlled) | No (passive) |
| Diagnostic function? | Yes (ECG recording, arrhythmia detection) | Yes (blood glucose measurement) | No (surgical assistance/laparoscopy) | No (barrier protection only) |
| Therapeutic function? | No | No (monitoring only) | Yes (enables minimally invasive surgery) | No |
| NMPA class if making health claims | Class II (medical device with active electronic diagnostic function) | Class II (non-calibrated) / Class III (calibrated for insulin dosing) | Class III (active surgical device, life-supporting function) | Class I (non-sterile) / Class II (sterile, antimicrobial claims) |
This decision matrix illustrates a key point: borderline classifications often hinge on specific claims or device features rather than the device category alone. A smartwatch that only measures heart rate for fitness purposes falls outside the NMPA device classification system entirely (it is a consumer product). However, the same smartwatch with an ECG function and diagnostic claims for arrhythmia detection becomes a Class II medical device. Similarly, a sterile surgical gown is Class II if marketed as sterile and intended for use in surgical settings, but Class I if non-sterile and intended for examination use only.
Classification Pitfalls and How to Avoid Them
Foreign manufacturers commonly make several classification errors that lead to application delays, enforcement action, or unnecessary costs. The following pitfalls are the most frequently encountered:
- Pitfall 1: Relying on FDA or EU Classification Equivalents — A device classified as Class II in the US (FDA 510(k)) or Class IIa in the EU (MDR) may be classified as Class III in China due to the NMPA’s different risk assessment methodology. For example, certain implantable orthopedic fixation devices are Class II in the EU but Class III in China. Never assume your device’s international classification transfers to the NMPA system — always verify independently.
- Pitfall 2: Misclassifying Combination Products — Devices incorporating medicinal substances (drug-coated balloons, antibiotic bone cement), biological components (tissue-engineered products), or animal-derived materials follow special classification rules under the NMPA’s combination product guidelines. These devices are routinely classified at Class III regardless of the base device classification, and may require consultation with both the NMPA Medical Device Registration Division and the Center for Drug Evaluation (CDE).
- Pitfall 3: Ignoring Accessories in Classification — Accessories to medical devices are classified based on their own risk profile, not the parent device’s classification. A Class III implant’s external programming unit may be Class II, while a Class II diagnostic device’s biopsy needle may be Class III. Each component of a system must be classified independently.
- Pitfall 4: Unsupported Classification Downward Shifts — Some foreign manufacturers intentionally classify their device at a lower risk level to reduce costs and regulatory burden, only to have the application rejected or require reclassification during review. The NMPA’s Classification Division has the authority to reclassify devices during the application review process, and such reclassification typically adds 6–12 months to the timeline and requires new application fees. Honest classification upfront is always the lower-risk strategy.
- Pitfall 5: Classification of Software as a Medical Device (SaMD) — China has its own SaMD classification framework under the Medical Device Software Classification Guidelines (2022). Standalone medical software, AI-based diagnostic support tools, and clinical decision support systems may be classified as Class II or III medical devices even though they have no physical form. The classification depends on the software’s intended use, the significance of the information it provides, and whether it automates clinical decisions.
Classification Benchmarks by Device Category
The following reference table provides the standard NMPA classification for the most commonly imported medical device categories, based on the official Classification Catalog and confirmed by recent registration data. Use this table as a rapid cross-check against your own classification analysis:
| Device Category | Catalog Code | NMPA Class | Typical Pathway | Common Classification Issues |
|---|---|---|---|---|
| Non-powered surgical instruments (scissors, forceps, retractors) | 6801, 6802 | Class I | Filing | Sterility claims push to Class II |
| Electrosurgical instruments and generators | 6823 | Class II | Registration | If implantable electrodes → Class III |
| Diagnostic ultrasound systems | 6823 | Class II | Registration | Contrast-enhanced ultrasound → Class III |
| X-ray diagnostic equipment | 6830 | Class II | Registration | CT systems → Class III |
| In vitro diagnostic reagents (clinical chemistry) | 6840 | Class II | Registration | Tumor marker or genetic tests → Class III |
| Cardiovascular stents (bare metal and drug-eluting) | 6846 | Class III | Registration + clinical trial | Always Class III regardless of coating |
| Orthopedic joint implants | 6846 | Class III | Registration + clinical trial | Custom-make patient-specific implants still Class III |
| Dental implant systems | 6863 | Class III | Registration + clinical trial | Non-implant dental materials → Class II |
| Patient monitoring systems (bedside) | 6821 | Class II | Registration | Telemedicine monitoring → Class III with data transmission |
| Medical imaging software (AI diagnostic support) | 6821 (software sub-class) | Class II–III | Registration | Depends on whether software provides diagnostic conclusion |
This reference table should be used as a starting point only. The specific intended use, technical specifications, and claims made for your device may move it to a different classification than the standard category suggests. When in doubt, the safest approach is to submit a pre-classification inquiry to the CMDE Classification Division, which provides an official classification determination within 20–30 working days at no cost.
Where to Go From Here
After determining your device’s likely NMPA classification using this tool, the next step is to validate your classification through the official CMDE pre-classification process and begin building your registration budget based on the classification-specific cost ranges. An accurate classification is the foundation of a realistic registration timeline, budget, and resource plan.
For a detailed cost estimate based on your device’s classification, use our China Medical Device Registration Cost Estimator. If you need a comprehensive overview of the NMPA registration process from classification to post-market compliance, see our Essential China NMPA Registration Resources for Foreign Medical Device Companies. For guidance on the clinical trial requirements that apply to Class II and III devices specifically, explore our Essential China Medical Device Clinical Trial Resources for Foreign Sponsors.
China Medical Device Classification Assistance Tool — first published on China Gateway 360. Last updated: July 2026.
